Therapeutic potential of 9-(2-phosphonylmethoxyethyl)adenine (PMEA) as an antiviral drug

Lieve Naesens; Jan Balzarini; De Clercq Erik

Back

Therapeutic potential of 9-(2-phosphonylmethoxyethyl)adenine (PMEA) as an antiviral drug

Article 1994 en

Discussion(0)

No comments yet. Be the first to comment.

Related publications

Article1994

Therapeutic potential of PMEA as an antiviral drug

Lieve Naesens, Jan Balzarini, De Clercq Erik

Article1998

Comparison of the Disposition of Ester Prodrugs of the Antiviral Agent 9-(2-phosphonylmethoxyethyl)adenine [PMEA] in Caco-2 Monolayers

Pieter Annaert, Gilles Gosselin, Alain Pompon, S. Benzaria, Gilles Valette, J.‐L. IMBACH, Lieve Naesens, Sigrid Hatse, De Clercq Erik, Guy Van den Mooter, Renaat Kinget, Patrick Augustijns

Article1995

Antiviral efficacy in mice of oral bis(POM)-PMEA, the Bis(pivaloyloxymethyl) ester prodrug of 9-(2-phosphonylmethoxyethyl)adenine

Lieve Naesens, Johan Neyts, Jan Balzarini, N. Bischofberger, De Clercq Erik

Article1993

Therapeutic potential of HPMPC as an antiviral drug

De Clercq Erik

Article1995

In vivo Antiretroviral Efficacy of Oral bis(POM)-PMEA, the bis(Pivaloyloxymethyl)prodrug of 9-(2-Phosphonylmethoxyethyl) adenine (PMEA)

Lieve Naesens, Johan Neyts, Jan Balzarini, N. Bischofberger, De Clercq Erik